Targeted Therapies For Atopic Dermatitis: On the Cusp of a Golden Era
Format: Webcourse
Credit(s): 1.00 (60 min)
Release Date: Feb 08, 2022
Expiration Date: Feb 08, 2023
Credit Type(s):
- MIPS Improvement Activity Under MACRA
- Physicians – AMA PRA Category 1 Credit(s) ™
- Physicians/ABIM MOC – ABIM MOC Point(s)
PROGRAM OVERVIEW
“Targeted Therapies For Atopic Dermatitis: On the Cusp of a Golden Era?” aims to provide allergists and dermatologists with up-to-date information on management of moderate to severe AD, including the health burden of uncontrolled disease, identification of patients with more severe disease who require treatment escalation, evidence-based use of newer targeted therapies, and how emerging therapies may impact AD management in the near term.
PROVIDER
Jointly provided by the Potomac Center for Medical Education and Rockpointe
Patient Resources Provided by
This program is supported by an educational grant from Sanofi Genzyme and Regeneron Pharmaceuticals.
RELATED COURSES
Diagnosing and Managing Pustular Psoriasis: A Rare But Serious Disease
Credits 1.00 (60 min)
Format Webcourse
Advances in Skin Cancer Diagnosis: Using New Technologies to Identify High-Risk Patients
Credits 1.00 (60 min)
Format Webcourse
08
Feb
Feb
